Product Information

SUMATRIPTAN 6 MG/0.5 ML AUTOINJ is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $59.4096 per ML under NDC 47335027641. Its NADAC has been published 677 times since Nov 28, 2013.

FDA first approved this application on Jun 21, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

SUMATRIPTAN 6 MG/0.5 ML AUTOINJ

Sumatriptan Succinate
$59.4096per ML

Strength

6 mg/.5mL

NDC

47335027641

Classification

Generic

Dosage Form

INJECTION

Route

SUBCUTANEOUS

Effective Date

10/21/2026

Active Ingredients

SUMATRIPTAN SUCCINATE

Approval Type

Generic (ANDA)

FDA Application

ANDA090358

FDA Approved

6/21/2011

TE Code

AB

On Market Since

8/20/2025

Pharmacological Classes

Serotonin 1b Receptor Agonists
Serotonin 1d Receptor Agonists
Serotonin-1b and Serotonin-1d Receptor Agonist

Price Statistics

The NADAC for SUMATRIPTAN 6 MG/0.5 ML AUTOINJ has been published 677 times since Nov 28, 2013, and over the history we have for it it has declined 57.4%. The table below summarizes its recorded NADAC range and movement.

Current price$59.4096 per ML
All-time high$153.0292 (Jan 11, 2017)
All-time low$46.6942 (May 22, 2024)
52-week high$75.8160
52-week low$59.4096
Median price$84.4838
Average price$95.1225
Largest weekly change+61.1% (Jun 19, 2024)
Weeks tracked677
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

-3.3%

3M

-5.6%

6M

-15.3%

1Y

-18.0%

3Y

-6.8%

5Y

-23.1%

All

-57.4%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 75% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of SUMATRIPTAN 6 MG/0.5 ML AUTOINJ?

The current National Average Drug Acquisition Cost (NADAC) for SUMATRIPTAN 6 MG/0.5 ML AUTOINJ, manufactured by Sun Pharmaceutical Industries Inc., is $59.4096 per ML (NDC 47335027641), effective Nov 11, 2026.

How has the price of SUMATRIPTAN 6 MG/0.5 ML AUTOINJ changed over time?

Over the history we have for it, the NADAC for SUMATRIPTAN 6 MG/0.5 ML AUTOINJ has declined 57.4%. It has been tracked across 677 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for SUMATRIPTAN 6 MG/0.5 ML AUTOINJ?

Since Nov 28, 2013, the NADAC for SUMATRIPTAN 6 MG/0.5 ML AUTOINJ has ranged from a low of $46.6942 (May 22, 2024) to a high of $153.0292 (Jan 11, 2017), with a median of $84.4838 per ML.

Are there cheaper alternatives to SUMATRIPTAN 6 MG/0.5 ML AUTOINJ?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SUMATRIPTAN 6 MG/0.5 ML VIAL, is $15.0000 per ML — about 75% below SUMATRIPTAN 6 MG/0.5 ML AUTOINJ.

Who manufactures SUMATRIPTAN 6 MG/0.5 ML AUTOINJ?

SUMATRIPTAN 6 MG/0.5 ML AUTOINJ (NDC 47335027641) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.